| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/25/2006 | US20060111406 Amide linker peroxisome proliferator activated receptor modulators |
| 05/25/2006 | US20060111400 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 05/25/2006 | US20060111397 Methods and compositions for treating diseases associated with excesses in ACE |
| 05/25/2006 | US20060111390 Azaindoles as inhibitors of c-jun n-terminal kinases |
| 05/25/2006 | US20060111380 4-(2-naphtyl)-2-[3-oxospiro[isobenzofuran-1 (3H), 4'-piperidin]-1'-yl]-1H-imidazole, 4-(4-bromophenyl)-2-[3-oxospiro[isobenzofuran-1(3H),4'-piperidin]-1-yl]-1H imidazole; metabolic, genitalor reproductive, gastro-intestinal, respiratory system disorders, antiinflammatory agent or glaucoma; cyclization |
| 05/25/2006 | US20060111375 Compound having tgfß inhibitory activity and medicinal composition containing the same |
| 05/25/2006 | US20060111374 N-(3-amino-propyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl)-2-methyl-propyl]-4-methyl-benzamide; kinesin spindle protein inhibitor; cell division, mitosis phase arrest; antiproliferative and antiinflammation agent, hyperplasias, restenosis, cardiac hypertrophy, autoimmune disorders |
| 05/25/2006 | US20060111368 Phosphodiesterase inhibitor |
| 05/25/2006 | US20060111362 1,3-Dihydroimidazole ring compound |
| 05/25/2006 | US20060111340 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 05/25/2006 | US20060111329 Anticancer Agents Based on Regulation of Protein Prenylation |
| 05/25/2006 | US20060111322 Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation |
| 05/25/2006 | US20060111304 For therapy of pancreatitus, bilioecholic, gastroesophical relux (GERD), irritable bowel syndrome (IBS), non ulcerous dyspepsia |
| 05/25/2006 | US20060111290 Stromal-Derived Factor-1 (SDF), G-CSF (granulocyte-colony stimulating factor), stimulating vasculogenesis; improves cardiac function |
| 05/25/2006 | US20060111280 Novel substance fki-1033 and process for producing the same |
| 05/25/2006 | US20060111278 TFF peptides |
| 05/25/2006 | US20060111274 Methods and compositions for enhancing transport across biological membranes |
| 05/25/2006 | US20060111235 Method of manufacturing ferromagnetic particle exothermic elements |
| 05/25/2006 | US20060110474 Rubrofusarin glycoside-containing composition |
| 05/25/2006 | US20060110443 toxic or potent core is incorporated into the dosage form via three-dimensional printing, as a solution, solubilization or suspension of solid particles in liquid, rather than by the more conventional handling and compressing of dry powder; allows greater bioavailability |
| 05/25/2006 | US20060110384 Novel proteins and use thereof |
| 05/25/2006 | US20060110363 Comprises chimeric polypeptide associated with uracil phosphoribosyl transferase (UPRTase) treating proliferative and infectious diseases; gene therapy; antiproliferative agents; suicide genes |
| 05/25/2006 | US20060110361 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 05/24/2006 | EP1659177A2 Secreted and transmembrane polypeptides and nucleic acids ancoding the same |
| 05/24/2006 | EP1659176A1 Oligonucleotide inhibiting the expression of star-binding protein (sbp) gene and method therefor |
| 05/24/2006 | EP1659172A1 Adipogenic differentiation of human mesenchymal stem cells |
| 05/24/2006 | EP1659131A2 Polypeptides and nucleic acids encoding the same |
| 05/24/2006 | EP1659125A1 Triptolide analogs for the treatment of autoimmune and inflammatory disorders |
| 05/24/2006 | EP1659123A1 Bicyclic pyrazole derivative |
| 05/24/2006 | EP1659121A1 1,3-dihydro-2h-indol-2-one derivative |
| 05/24/2006 | EP1659120A1 3-substituted quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
| 05/24/2006 | EP1659117A1 2-naphthylimino-1,3-thiazine derivative |
| 05/24/2006 | EP1659114A2 Process for the preparation of bicyclo[3.2.1]octane fused with quinazoline derivatives |
| 05/24/2006 | EP1658860A1 Drug compositions comprising anticholinergics and EGFR kinase inhibitors |
| 05/24/2006 | EP1658849A2 Therapeutic combinations of antihypertensive and antiangiogenic agents |
| 05/24/2006 | EP1658074A1 Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers |
| 05/24/2006 | EP1658049A2 Ferromagnetic particles and methods |
| 05/24/2006 | EP1506185B1 Compounds and their use as inhibitors of 5-ht |
| 05/24/2006 | EP1478613B1 Substituted 10-aryl-11h-benzo¬b|fluorenes for selective effects on estrogen receptors |
| 05/24/2006 | EP1474425B1 Deazapurines and uses thereof |
| 05/24/2006 | EP1471944B1 Pharmaceutical composition which improves in vivo gene transfer |
| 05/24/2006 | EP1466614A4 Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon |
| 05/24/2006 | EP1458378B1 Amino acid derivatives useful for the treatment of alzheimer's disease |
| 05/24/2006 | EP1453431A4 Method and apparatus for the stimulation of hair growth |
| 05/24/2006 | EP1409705B1 A process for the production of an inhibitor of human platelet aggregation and soybean lipoxygenase |
| 05/24/2006 | EP1389619B1 Pkb-3564 substance with neovascularization inhibitory activity |
| 05/24/2006 | EP1384477B1 Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases |
| 05/24/2006 | EP1383480A4 Lipid-comprising drug delivery complexes and methods for their production |
| 05/24/2006 | EP1370526B1 Diamides which inhibit tryptase and factor xa activity |
| 05/24/2006 | EP1363912B1 Substituted imidazotriazinones |
| 05/24/2006 | EP1355900B1 Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands |
| 05/24/2006 | EP1341778B1 Klainetin and derivatives thereof, method for their production and the use of the same |
| 05/24/2006 | EP1337550B1 Hepatitis c tripeptide inhibitors |
| 05/24/2006 | EP1334106B1 Imidazole derivatives, production method thereof and use thereof |
| 05/24/2006 | EP1333841B1 M. tuberculosis chaperonin 10 and uses thereof |
| 05/24/2006 | EP1322383B1 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 05/24/2006 | EP1212410B1 Dna encoding the human serine protease eos |
| 05/24/2006 | EP1212298B1 Isolation of natural l-beta-3-indolylalanine and enrichment of natural aliphatic amino acid mixtures with natural l-beta-3-indolylalanine |
| 05/24/2006 | EP1115397B1 Compositions for mitigating the adverse effects of interleukin-2 |
| 05/24/2006 | EP1100492B1 INDOLE sPLA2 INHIBITORS |
| 05/24/2006 | EP1015585B1 Tie ligand homologues |
| 05/24/2006 | EP0946147B1 Composition suitable for the treatment of equine laminitis |
| 05/24/2006 | CN1777580A Prostaglandin derivatives |
| 05/24/2006 | CN1777413A Mmp expression inhibitor |
| 05/24/2006 | CN1775946A Enhanced virus-mediated DNA transfer |
| 05/24/2006 | CN1775801A Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 05/24/2006 | CN1775759A Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 05/24/2006 | CN1775268A Kidney-tonifying preparation and preparing method |
| 05/24/2006 | CN1775264A Maiwei-dihuang preparation and new preparing method |
| 05/24/2006 | CN1775263A Qiju-dihuang preparation and new preparation method |
| 05/24/2006 | CN1775259A Anemarrhena preparation and new preparation method |
| 05/24/2006 | CN1775239A Huanwu detoction for supplementing Yang, its preparing process and use |
| 05/24/2006 | CN1775226A Use of attenuated salmonella carraying human PF4 gene for chemotherapeutic protection and hematopoietic reconstitution |
| 05/24/2006 | CN1775207A Esmolol formulation |
| 05/24/2006 | CN1775059A Health-care tea containing antifatigue anti senility Chinese herbal medicine |
| 05/24/2006 | CN1775057A Process for preparing cold tea paste |
| 05/24/2006 | CN1257259C Formulation for health-care red rice wine |
| 05/24/2006 | CN1257177C Circular muscle glycoside diphosphoethoxymethyl ribose compound |
| 05/24/2006 | CN1257169C Bicyclic imidazo-3-yl-amine derivatives |
| 05/24/2006 | CN1257160C Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
| 05/24/2006 | CN1256978C Medicine for tonifying kidney, promoting generation of vital essence and reinforcing primordial qi, and strengthening and its preparing method |
| 05/24/2006 | CN1256963C Antifatigue medicine and its preparation method |
| 05/23/2006 | US7049455 Process for producing shogaols and intermediates for the synthesis thereof |
| 05/23/2006 | US7049445 for treating or preventing diabetes, obesity, hyperlipidemia, digestive diseases, depression or urinary disturbances; beta 3-agonist |
| 05/23/2006 | US7049443 Such as 2-(3-(Acetyl(((5S)-3-(4-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-3 -fluorophenyl)-2-oxo-1,3-oxazolidin-5-yl)meth yl)amino)-1,1-dimethyl-3-oxopropyl)-3,5-dimethylphenyl dihydrogen phosphate; improved bioavailability |
| 05/23/2006 | US7049439 Immunomodulators for inducing cytokine biosynthesis; viricides; antitumor agents |
| 05/23/2006 | US7049403 Insulin/IGF/relaxin family polypeptides and DNAS thereof |
| 05/23/2006 | US7049402 Tumor necrosis factor receptor-5 |
| 05/23/2006 | US7049343 Nitrogen compounds such as 3-(N'-(2,6-dinitro-4-trifluoro methylphenyl)-N-(3-methoxyphenylhydrazino)propionic acid, used as glycine transport antagonists for prophylaxis of psychological disorders |
| 05/23/2006 | US7049336 Method for diagnosing neuronal diseases and for treating primary hemostasis deficiency |
| 05/23/2006 | US7049335 3-azabicyclo[3.1.0]hexane derivatives |
| 05/23/2006 | US7049331 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 05/23/2006 | US7049329 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists |
| 05/23/2006 | US7049326 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots |
| 05/23/2006 | US7049325 Quinoline derivatives as anti-inflammatory agents |
| 05/23/2006 | US7049322 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 05/23/2006 | US7049321 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor |
| 05/23/2006 | US7049317 CCR-3 receptor antagonists |
| 05/23/2006 | US7049316 Prodrugs of CC-1065 analogs |
| 05/23/2006 | US7049315 Solubilized topoisomerase poisons |